Skip to main content

Advertisement

SpringerLink
Log in

Strategies for repeat prostate biopsies

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Urologists are routinely faced with the dilemma of a persistently worrisome clinical picture for prostate cancer in patients who have undergone prior negative ultrasound-guided prostate biopsies. Indications for repeat biopsy include sustained or worsening of the findings that prompted the initial biopsy; various derivations of prostate-specific antigen; and the histology from the initial biopsy (ie, high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation is identified). Large prostate volume or inflammation can confound the decision to perform repeat biopsies. Repeat biopsies should include a combination of standard sextant, lateral, anterior apical, and possibly transition zone biopsies. Repeat biopsies should consist of at least 14 cores but may include more than 36 samples. In patients who are not at high risk for prostate cancer, more than two sets of repeat biopsies have a very low yield.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Terris MK: Prostate biopsy strategies: past, present, and future. Urol Clin North Am 2002, 29:205–212.

    Article  PubMed  Google Scholar 

  2. Djavan B, Remzi M, Schulman CC, et al.: Repeat prostate biopsy: who, how and when? A review. Eur Urol 2002, 42:93–103.

    Article  PubMed  Google Scholar 

  3. Busby JE, Evans CP: Determining variables for repeat prostate biopsy. Prostate Cancer Prostatic Dis 2004, 7:93–98.

    Article  CAS  PubMed  Google Scholar 

  4. Djavan B, Fong YK, Ravery V, et al.: Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A multi-institutional prospective European study. Eur Urol 2005, 47:38–44.

    Article  PubMed  Google Scholar 

  5. Catalona WJ, Partin AW, Slawin KM, et al.: Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998, 279:1542–1547.

    Article  CAS  PubMed  Google Scholar 

  6. Morgan TO, McLeod DG, Leifer ES, et al.: Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen. Urology 1996, 48:76–80.

    Article  CAS  PubMed  Google Scholar 

  7. Keetch DW, McMurtry JM, Smith DS, et al.: Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. J Urol 1996, 156:428–431.

    Article  CAS  PubMed  Google Scholar 

  8. Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL: Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000, 163:158–162.

    Article  CAS  PubMed  Google Scholar 

  9. Raaijmakers R, Wildhagen M, Ito K: Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam. Urology 2004, 63:316–320.

    Article  PubMed  Google Scholar 

  10. Hässler O, Epstein JI, Amin MB, et al.: Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer. Hum Pathol 1999, 30:1077–1086.

    Article  Google Scholar 

  11. Orozco R, O’Dowd G, Kunnel B, et al.: Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States. Urology 1998, 51:186–195.

    Article  CAS  PubMed  Google Scholar 

  12. Schoenfield L, Jones JS, Zippe CD, et al.: The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. BJU Int 2007, 99:770–774.

    Article  CAS  PubMed  Google Scholar 

  13. Meng MV, Shinohara K, Grossfeld GD: Significance of high-grade prostatic intraepithelial neoplasia on prostate biopsy. Urol Oncol 2003, 21:145–151.

    PubMed  Google Scholar 

  14. O’Dowd GJ, Miller MC, Orozco R, Veltri RW: Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology 2000, 55:553–559.

    Article  PubMed  Google Scholar 

  15. Zlotta AR, Schulman CC: Clinical evolution of prostatic intraepithelial neoplasia. Eur Urol 1999, 35:498–503.

    Article  CAS  PubMed  Google Scholar 

  16. Presti JC Jr: Prostate biopsy strategies. Nat Clin Pract Urol 2007, 4:505–511.

    Article  PubMed  Google Scholar 

  17. Bostwick DG, Srigley J, Grignon D, et al.: Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 1993, 24:819–832.

    Article  CAS  PubMed  Google Scholar 

  18. Rietbergen JBW, Boeken Kruger AE, Hoedemaeker RF, et al.: Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer. J Urol 1998, 160:2121–2125.

    Article  CAS  PubMed  Google Scholar 

  19. Chen ME, Troncoso P, Johnston D, et al.: Prostate cancer detection: relationship to prostate size. Urology 1999, 53:764–768.

    Article  CAS  PubMed  Google Scholar 

  20. Remzi M, Djavan B, Wammack R, et al.: Can total and transition zone volume of the prostate determine whether to perform a repeat biopsy? Urology 2003, 61:161–166.

    Article  CAS  PubMed  Google Scholar 

  21. Basillote JB, Armenakas NA, Hochberg DA, Fracchia JA: Influence of prostate volume in the detection of prostate cancer. Urology 2003, 61:167–171.

    Article  PubMed  Google Scholar 

  22. Ung JO, San Francisco IF, Regan MM, et al.: The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection. J Urol 2003, 169:130–135.

    Article  PubMed  Google Scholar 

  23. Sajadi KP, Kim T, Terris MK, et al.: High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates. Urology 2007, 70:691–695.

    Article  PubMed  Google Scholar 

  24. Okada K, Kojima M, Naya Y, et al.: Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer. Urology 2000, 55:892–898.

    Article  CAS  PubMed  Google Scholar 

  25. Hasui Y, Marutsuka K, Asada Y, et al.: Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 1994, 25:91–96.

    Article  CAS  PubMed  Google Scholar 

  26. Nadler RB, Humphrey PA, Smith DS, et al.: Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995, 154:407–413.

    Article  CAS  PubMed  Google Scholar 

  27. Morote J, Lopez M, Encabo G, de Torres IM: Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen. Eur Urol 2000, 37:537–540.

    Article  CAS  PubMed  Google Scholar 

  28. Abouassaly R, Tan N, Moussa A, Jones JS: Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies. J Urol 2008, 180:911–914.

    Article  PubMed  Google Scholar 

  29. Davis M, Sofer M, Kim SS, Soloway MS: The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol 2002, 167:566–570.

    Article  PubMed  Google Scholar 

  30. Ochiai A, Babaian RJ: Update on prostate biopsy technique. Curr Opin Urol 2004, 14:157–162.

    Article  PubMed  Google Scholar 

  31. Feliciano J, Teper E, Ferrandino M, et al.: The incidence of fluoroquinolone resistant infections after prostate biopsy: are fluoroquinolones still effective prophylaxis? J Urol 2008, 179:952–955.

    Article  PubMed  Google Scholar 

  32. Hong YM, Lai FC, Chon CH, et al.: Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies. Urol Oncol 2004, 22:7–10.

    PubMed  Google Scholar 

  33. Kamoi K, Troncoso P, Babaian RJ: Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia. J Urol 2000, 163:819–823.

    Article  CAS  PubMed  Google Scholar 

  34. Shepherd D, Keetch DW, Humphrey PA, et al.: Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy. J Urol 1996, 156:460–462.

    Article  CAS  PubMed  Google Scholar 

  35. Patel AR, Jones JS, Zhou M, et al.: Parasagittal biopsies are more important as part of an initial biopsy strategy than as part of a repeat biopsy strategy: observations from a unique population. Prostate Cancer Prostatic Dis 2007, 10:352–355.

    Article  CAS  PubMed  Google Scholar 

  36. Stamey TA: Making the most out of six systematic sextant biopsies. Urology 1995, 45:2–12.

    Article  CAS  PubMed  Google Scholar 

  37. Eskew LA, Bare RL, McCullough DL: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997, 157:199–202.

    Article  CAS  PubMed  Google Scholar 

  38. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K: The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000, 163:163–166.

    Article  PubMed  Google Scholar 

  39. Mian BM, Naya Y, Okihara K, et al.: Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology 2002, 60:836–840.

    Article  PubMed  Google Scholar 

  40. Babaian RJ, Toi A, Kamoi K, et al.: A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000, 163:152–157.

    Article  CAS  PubMed  Google Scholar 

  41. Terris MK, McNeal JE, Stamey TA: Transrectal ultrasound imaging and ultrasound guided prostate biopsies in the detection of residual carcinoma in clinical stage A carcinoma of the prostate. J Urol 1992, 146:864–869.

    Google Scholar 

  42. Liu IJ, Macy M, Lai YH, Terris MK: Critical evaluation of the current indications for transition zone biopsies. Urology 2001, 57:1117–1120.

    Article  CAS  PubMed  Google Scholar 

  43. Fleshner N, Klotz L: Role of “saturation biopsy” in the detection of prostate cancer among difficult diagnostic cases. Urology 2002, 6:93–97.

    Article  Google Scholar 

  44. Meng MV, Franks JH, Presti JC Jr, Shinohara K: The utility of apical anterior horn biopsies in prostate cancer detection. Urol Oncol 2003, 21:361–365.

    PubMed  Google Scholar 

  45. Wright JL, Ellis WJ: Improved prostate cancer detection with anterior apical prostate biopsies. Urol Oncol 2006, 24:492–495.

    PubMed  Google Scholar 

  46. Stewart CS, Leibovich BC, Weaver AL, Lieber MM: Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001, 166:86–92.

    Article  CAS  PubMed  Google Scholar 

  47. Jones JS, Patel A, Schoenfield L: Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 2006, 175:485–488.

    Article  PubMed  Google Scholar 

  48. Ashley RA, Inman BA, Routh JC, et al.: Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol 2008, 53:976–981.

    Article  PubMed  Google Scholar 

  49. Igel TC, Knight MK, Young PR: Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk. J Urol 2001, 165:1575–1579.

    Article  CAS  PubMed  Google Scholar 

  50. Pinkstaff DM, Igel TC, Petrou SP, et al.: Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. Urology 2005, 65:735–739.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical College of Georgia, 1120 Fifteenth Street, BA 8414, Augusta, GA, 30912-4050, USA

    Martha K. Terris

Authors
  1. Martha K. Terris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martha K. Terris.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terris, M.K. Strategies for repeat prostate biopsies. Curr Urol Rep 10, 172–178 (2009). https://doi.org/10.1007/s11934-009-0030-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-009-0030-y

Keywords

Search

Navigation